Pre-filled Syringes & Primary Packaging
Container closure integrity, extractables and leachables, material compatibility, primary container selection and component integration.
Two days of technical insight, practical case studies and professional networking focused on the development, engineering and commercialisation of injectable drug-device combination products.
Explore registration options →Explore the technical, regulatory and manufacturing challenges shaping injectable drug delivery, from primary container selection to the complete device lifecycle.
Container closure integrity, extractables and leachables, material compatibility, primary container selection and component integration.
High-concentration formulations, high-viscosity products, larger injection volumes and solutions for reliable subcutaneous administration.
Next-generation injection platforms, near-body and on-body delivery, electromechanical systems and durable versus disposable technologies.
Design for manufacturing, drive systems, robotics, automation, assembly processes, performance verification and scalable industrial solutions.
Integration of the drug, primary container and delivery device, including design controls, platform selection, risk management and commercialisation.
Article 117 of the EU MDR, Notified Body Opinions, combination product assessments, global regulatory expectations and quality requirements.
Usability engineering, inclusive design, patient needs, simulated-use testing and human factors considerations throughout device development.
Fill-finish operations, sterile manufacturing, Annex 1 expectations, inspection readiness and process control for injectable products.
Innovative elastomeric materials, sustainable device design, circularity, lifecycle considerations and reduced environmental impact.
Designed for senior decision-makers, technical specialists and industry professionals involved in the development, manufacture and commercialisation of injectable products.
More than a series of presentations: a focused environment for exchanging experience, discussing common challenges and building industry connections.
Practical insights from professionals working directly on injectable product and device development.
Different perspectives from pharmaceutical companies, device manufacturers and technical specialists.
Connect with industry peers, solution providers and potential collaborators throughout the conference.
Extend discussions beyond the conference room with the pre-conference cocktail and conference dinner.
Through its specialised pharmaceutical and biotechnology conferences, EPM Group connects professionals and organisations across the global life sciences industry.
Organisations associated with the wider EPM Group conference network. This selection does not represent confirmed sponsors or attendees of INJECTA Summit 2027.
Join the professionals advancing injectable drug delivery, combination products and medical device innovation.